Events & Presentations       Publications 


March 29, 2022, an article was published in the open access journal Cancers: "Elevated MACC1 Expression in Colorectal Cancer Is Driven by Chromosomal Instability and Is Associated with Molecular Subtype and Worse Patient Survival" by V. Vuaroqueaux et al.


October 28, 2021, an article in the nature partner journal Precision Oncology was published: "Pharmacogenomics characterization of the MDM2 inhibitor MI-773 reveals candidate tumours and predictive biomarkers" by V. Vuaroqueaux et al.



March 13, 2020, an article in the European Journal of Medicinal Chemistry was published: "A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia" by A. Sellmer et al.